Copertina

Topoisomerase IIb binding delineates localized mutational processes and driver mutations in cancer genomes

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Reimand, Jüri
Natura:	Recurso digital
Pubblicazione:	Zenodo 2025
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder†
di: Tibor Szarvas, et al.
Pubblicazione: (2024)

Poisson process factorization for mutational signature analysis with genomic covariates
di: Zito, Alessandro, et al.
Pubblicazione: (2025)

Identifying actionable driver mutations in lung cancer using an efficient Asymmetric Transformer Decoder
di: Brattoli, Biagio, et al.
Pubblicazione: (2025)

Predicting mutational effects on protein binding from folding energy
di: Deng, Arthur, et al.
Pubblicazione: (2025)

Meta‐analysis of the ability of mutational profiles on the cancer genome atlas to predict prognosis in endometrial carcinoma
di: Yi‐xiang Li, et al.
Pubblicazione: (2025)

Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations
di: Xiao‐lian Liu, et al.
Pubblicazione: (2024)

Cohesin mutations and chromatin changes in cancer
di: Ariel D. Swett, et al.
Pubblicazione: (2025)

Effects of local mutations in quadratic iterations
di: Radulescu, Anca, et al.
Pubblicazione: (2020)

Exploiting Liver CT scans in Colorectal Carcinoma genomics mutation classification
di: Perlo, Daniele, et al.
Pubblicazione: (2024)

A contact process with stronger mutations on trees
di: Lopes, Fábio, et al.
Pubblicazione: (2025)

The mutation process on the ancestral line under selection
di: Baake, Ellen, et al.
Pubblicazione: (2023)

Geometry of tropical mutation surfaces with a single mutation
di: Oda, Tomoki
Pubblicazione: (2025)

The prognostic impact of non‐driver gene mutations and variant allele frequency in primary myelofibrosis
di: Alberto Hernández‐Sánchez, et al.
Pubblicazione: (2024)

The IARC TP53 mutation database: a resource for studying the significance of TP53 mutations in human cancers
di: AUDREY PETITJEAN
Pubblicazione: (2007)

Tissue specific per base pair resolution exome and genome mutation susceptibilities
di: Schmalohr, Corinna, et al.
Pubblicazione: (2025)

Founder mutations
Pubblicazione: (2005)

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer
di: Marium T. Siddiqui, et al.
Pubblicazione: (2025)

Propagation of weakly advantageous mutations in cancer cell population
di: Polanski, Andrzej, et al.
Pubblicazione: (2023)

Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self‐supervised deep learning
di: Qingyuan Zheng, et al.
Pubblicazione: (2024)

Deep‐targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma
di: Menglin Xiao, et al.
Pubblicazione: (2024)

Defining short linear motif binding determinants by phage display‐based deep mutational scanning
di: Caroline Benz, et al.
Pubblicazione: (2025)

Differential effects of RAS mutations on chemoradiotherapy and total neoadjuvant therapy in locally advanced rectal cancer
di: Erina Haraguchi, et al.
Pubblicazione: (2025)

Comprehensive cross cancer analyses reveal mutational signature cancer specificity
di: Rui Xin, et al.
Pubblicazione: (2024)

Landscape and mutational dynamics of G-quadruplexes in the complete human genome and in haplotypes of diverse ancestry.
di: Chantzi, Nikol, et al.
Pubblicazione: (2025)

Oncogenic composite mutations can be predicted by co‐mutations and their chromosomal location
di: Asli Küçükosmanoglu, et al.
Pubblicazione: (2024)

Kinematic analysis of kinases and their oncogenic mutations – Kinases and their mutation kinematic analysis
di: Xiyu Chen, et al.
Pubblicazione: (2024)

Impact of secondary‐type mutations in acute myeloid leukemia with CEBPA mutation
di: Davidson Zhao, et al.
Pubblicazione: (2024)

Single-cell mutational burden distributions in birth-death processes
di: Morison, Christo, et al.
Pubblicazione: (2023)

Somatic mutational profiling and clinical impact of driver genes in Latin‐Iberian medulloblastomas: Towards precision medicine
di: Letícia Ganem Rillo Paz Barateiro, et al.
Pubblicazione: (2024)

Order-of-mutation effects on cancer progression: models for myeloproliferative neoplasm
di: Wang, Yue, et al.
Pubblicazione: (2023)

Comprehensive characterization of PKHD1 mutation in human colon cancer
di: Lu Han, et al.
Pubblicazione: (2024)

HER2 mutation as an emerging target in advanced breast cancer
di: Giulia Bon, et al.
Pubblicazione: (2024)

Functional, biochemical, and clinical characterization of natural mutations affecting arginine residues in the heparin‐binding site of antithrombin
di: Rosa Cifuentes‐Riquelme, et al.
Pubblicazione: (2026)

Long mutation cycles
di: Fomin, Sergey, et al.
Pubblicazione: (2023)

Radiation and human mutation
di: H. J. Muller
Pubblicazione: (1952)

A case of double‐negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab
di: Hiroki Tanaka, et al.
Pubblicazione: (2024)

The mutation atlas of giant kelp (): a mutation database resource for natural knockouts.
di: Diesel, Jose Francisco, et al.
Pubblicazione: (2024)

Synchronous endometrial/cervical and ovarian/fallopian tube carcinoma: a genome‐wide mutation analysis
di: Lihong Li, et al.
Pubblicazione: (2025)

Intratumoral heterogeneity of cancer driver genomic alterations in myxoid liposarcomas
di: Adrian Schmid, et al.
Pubblicazione: (2025)

Parametric estimation and LAN property of the birth-death-move process with mutations
di: Balsollier, Lisa, et al.
Pubblicazione: (2024)